Literature DB >> 7581751

Pediatricians' knowledge and attitudes concerning diagnosis and treatment of attention deficit and hyperactivity disorders. A national survey approach.

A Kwasman1, B J Tinsley, H S Lepper.   

Abstract

OBJECTIVE: To examine pediatricians' knowledge and attitudes concerning the diagnosis and treatment of attention deficit disorder (ADD) and attention-deficit hyperactivity disorders (ADHD).
DESIGN: Cross-sectional survey.
SETTING: United States. PARTICIPANTS: Three hundred eighty pediatricians comprising respondents from a random sample of 1000 members of the American Academy of Pediatrics.
INTERVENTIONS: None. MEASUREMENTS/MAIN
RESULTS: Pediatricians' perceptions of diagnostic modalities, child and family communication concerning ADD and ADHD diagnosis and treatment, and a variety of treatment issues were assessed in this study. Findings indicate that methylphenidate (Ritalin) hydrochloride is the most prescribed medication for treatment of ADD and ADHD. Pediatricians reported common parent and child misperceptions about ADD and ADHD treatment. Results suggest a wide range of reported physician behavior with respect to the diagnosis and treatment of ADD and ADHD.
CONCLUSION: Greater attention could be paid to providing accurate information in medical and educator training with respect to the cause, diagnosis, and treatment of ADD and ADHD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581751     DOI: 10.1001/archpedi.1995.02170240029004

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  5 in total

Review 1.  Promoting productive interactions between parents and physicians in the treatment of children with attention-deficit/hyperactivity disorder.

Authors:  William B Brinkman; Jeffery N Epstein
Journal:  Expert Rev Neurother       Date:  2011-04       Impact factor: 4.618

Review 2.  The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder.

Authors:  Stephen V Faraone
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-02       Impact factor: 4.785

3.  Prevalence of and change in the prescription of methylphenidate in Israel over a 2-year period.

Authors:  Yacov Fogelman; Shlomo Vinker; Nir Guy; Ernesto Kahan
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Shared decision-making to improve attention-deficit hyperactivity disorder care.

Authors:  William B Brinkman; Jessica Hartl Majcher; Lauren M Poling; Gaoyan Shi; Mike Zender; Heidi Sucharew; Maria T Britto; Jeffery N Epstein
Journal:  Patient Educ Couns       Date:  2013-05-10

5.  Comparison of Performance on ADHD Quality of Care Indicators: Practitioner Self-Report Versus Chart Review.

Authors:  Megan K Gordon; Rebecca A Baum; William Gardner; Kelly J Kelleher; Joshua M Langberg; William B Brinkman; Jeffery N Epstein
Journal:  J Atten Disord       Date:  2016-01-28       Impact factor: 3.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.